Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 243

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 243
---
 of COBRA premiums for up to 18 month from the date of termination,
and (iii) accelerated vesting of equity awards subject solely to service-based vesting as to the number of shares subject to such awards that would have otherwise vested had Dr. Desai continued to be employed by the Company for an
additional 18 months following termination of Dr. Desai’s employment, and (iv) Dr. Desai’s outstanding stock option awards will remain exercisable until the earlier of (a) 12 months following the date of
Dr. Desai’s termination of employment or (b) the expiration of the term of such stock option award set forth in the applicable stock option agreement.

Additionally, effective as of October 1, 2024, Dr. Desai became eligible to receive compensation pursuant to the terms of our Outside Director
Compensation Policy. Dr. Desai will continue to vest in his outstanding Company equity awards in accordance with their terms for the duration of time that he continues to serve as a member of our board of directors.

Transition Agreement and Release and Consulting Agreement with Loretta Itri, M.D.

Dr. Itri terminated employment as our Chief Medical Officer, effective as of October 1, 2024.

Pursuant to the terms of a Transition Agreement and Release entered into between Dr. Itri and the Company, dated September 16, 2024, Dr. Itri
became eligible to receive the following: (i) continuing payments of severance pay for a period of 12 months equal to the sum of (A)(x) 100% of Dr. Itri’s base salary rate, as in effect on the date of termination, plus (y) 100% of
Dr. Itri’s target bonus for 2024 (which will not be prorated for partial 2024 service), divided by (B) 12 (or, approximately $784,536 in the aggregate); and (ii) a lump sum payment equal to approximately $59,809, which represents the
cost of COBRA coverage for a period of 18 months from the date of termination.

Additionally, Dr. Itri and the Company have entered into a consulting
agreement pursuant to which, following the cessation of her employment, Dr. Itri will provide 10 hours of consulting and advisory services to the Company per month in exchange for a monthly retainer of $8,000. The consulting arrangement will
have an initial three-month term,